Comorbidities in chronic neuropathic pain

被引:188
作者
Nicholson, B
Verma, S
机构
[1] Penn State Univ, Sch Med, Allentown, PA 18103 USA
[2] Drexel Univ, Coll Med, Philadelphia, PA 19104 USA
关键词
comorbidities; chronic pain; neuropathic pain; sleep disturbances; depressed mood; anxiety;
D O I
10.1111/j.1526-4637.2004.04019.x
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Neuropathic pain arises from a lesion or dysfunction within the nervous system; the specific mechanisms that elicit neuropathic pain symptoms are the subject of ongoing research. It is generally acknowledged that neuropathic pain is extremely difficult to treat, and a major factor impacting outcomes is the presence of comorbidities such as poor sleep, depressed mood, and anxiety. Patients who suffer from chronic pain experience difficulties in initiating and maintaining sleep. Sleep deprivation has been associated with a decreased pain threshold, muscle aches, and stiffness in normal volunteers. The interrelationship of these factors is complex: Many chronic pain patients are depressed and anxious; sleep deprivation can lead to anxiety, and depression can be both the cause and the result of sleep disturbances. Thus, physicians must evaluate all aspects of pain, sleep, and mood in chronic pain patients. Several instruments have been developed to aid physicians in gathering qualitative and quantitative information from chronic pain patients. This triad of chronic pain, sleep disturbances, and depression/anxiety must be fully addressed if the patient is to be restored to optimal functionality. A multidisciplinary team approach allows for treatment of the whole patient. Nonpharmacologic interventions include relaxation therapy, sleep restriction therapy, and cognitive therapy. Strategies for pharmacologic interventions should attempt to maximize outcomes by employing, where possible, agents that address both the pain and the comorbidities. In this way, functionality may be restored and the patient's quality of life improved.
引用
收藏
页码:S9 / S27
页数:19
相关论文
共 107 条
[1]  
*AHCPR, 1993, DEPR PRIM CAR DET DI
[2]   The use of visual analog scales in mood disorders: A critical review [J].
Ahearn, EP .
JOURNAL OF PSYCHIATRIC RESEARCH, 1997, 31 (05) :569-579
[3]   Randomised crossover trial of transdermal fentanyl and sustained release oral morphine for treating chronic non-cancer pain [J].
Allan, L ;
Hays, H ;
Jensen, NH ;
de Waroux, BL ;
Bolt, M ;
Donald, R ;
Kalso, E .
BRITISH MEDICAL JOURNAL, 2001, 322 (7295) :1154-1158
[4]  
[Anonymous], 1994, Classification of chronic pain- Descriptions of chronic pain syndromes and definitions of pain terms
[5]   SUBJECTIVE SLEEP DISTURBANCE IN CHRONIC BACK PAIN [J].
ATKINSON, JH ;
ANCOLIISRAEL, S ;
SLATER, MA ;
GARFIN, SR ;
GILLIN, JC .
CLINICAL JOURNAL OF PAIN, 1988, 4 (04) :225-232
[6]   Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus - A randomized controlled trial [J].
Backonja, M ;
Beydoun, A ;
Edwards, KR ;
Schwartz, SL ;
Fonseca, V ;
Hes, M ;
LaMoreaux, L ;
Garofalo, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (21) :1831-1836
[7]  
Ballenger JC, 2001, J CLIN PSYCHIAT, V62, P53
[8]   Explaining high rates of depression in chronic pain: A diathesis-stress framework [J].
Banks, SM ;
Kerns, RD .
PSYCHOLOGICAL BULLETIN, 1996, 119 (01) :95-110
[9]  
BEASLEY CM, 1991, J CLIN PSYCHIAT, V52, P294
[10]  
Beck A T, 1974, Mod Probl Pharmacopsychiatry, V7, P151